Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2024-06-18 Sale |
2024-06-20 4:16 pm |
Esperion Therapeutics Inc. | ESPR | Warren Eric Chief Commercial Officer |
2,540 | $2.856 | $7,254 | 165,586 (Direct) |
View |
2024-05-17 Sale |
2024-05-20 4:14 pm |
Esperion Therapeutics Inc. | ESPR | Warren Eric Chief Commercial Officer |
192 | $2.483 | $477 | 168,126 (Direct) |
View |
2023-09-20 Sale |
2023-09-21 5:06 pm |
Esperion Therapeutics Inc. | ESPR | Warren Eric Chief Commercial Officer |
742 | $1.245 | $924 | 68,318 (Direct) |
View |
2023-08-18 Sale |
2023-08-21 4:32 pm |
Esperion Therapeutics Inc. | ESPR | Warren Eric Chief Commercial Officer |
243 | $1.414 | $344 | 69,060 (Direct) |
View |
2023-07-19 Sale |
2023-07-20 4:38 pm |
Esperion Therapeutics Inc. | ESPR | Warren Eric Chief Commercial Officer |
106 | $1.585 | $168 | 69,303 (Direct) |
View |
2023-06-21 Sale |
2023-06-22 4:45 pm |
Esperion Therapeutics Inc. | ESPR | Warren Eric Chief Commercial Officer |
603 | $1.483 | $894 | 69,409 (Direct) |
View |
2023-05-17 Sale |
2023-05-18 4:07 pm |
Esperion Therapeutics Inc. | ESPR | Warren Eric Chief Commercial Officer |
219 | $1.624 | $356 | 70,012 (Direct) |
View |
2023-05-10 Purchase |
2023-05-11 4:11 pm |
Esperion Therapeutics Inc. | ESPR | CARROLL J MARTIN Director |
31,500 | $1.5502 | $48,831 | 36,500 (Direct) |
View |
2023-05-10 Purchase |
2023-05-11 4:10 pm |
Esperion Therapeutics Inc. | ESPR | ROCAMBOLI STEPHEN Director |
8,111 | $1.495 | $12,126 | 8,111 (Direct) |
View |
2023-05-09 Purchase |
2023-05-10 4:12 pm |
Esperion Therapeutics Inc. | ESPR | Koenig Sheldon L. President and CEO |
20,000 | $1.2596 | $25,192 | 312,816 (Direct) |
View |
2023-04-19 Sale |
2023-04-20 4:12 pm |
Esperion Therapeutics Inc. | ESPR | Warren Eric Chief Commercial Officer |
115 | $1.278 | $147 | 70,231 (Direct) |
View |
2023-04-19 Sale |
2023-04-20 4:12 pm |
Esperion Therapeutics Inc. | ESPR | Looker Benjamin General Counsel |
1,290 | $1.272 | $1,641 | 83,663 (Direct) |
View |
2023-04-19 Sale |
2023-04-20 4:11 pm |
Esperion Therapeutics Inc. | ESPR | Foody Joanne M. Chief Medical Officer |
938 | $1.271 | $1,192 | 127,064 (Direct) |
View |
2023-03-17 Sale |
2023-03-20 4:19 pm |
Esperion Therapeutics Inc. | ESPR | Foody Joanne M. Chief Medical Officer |
3,808 | $1.7819 | $6,785 | 128,002 (Direct) |
View |
2023-03-17 Sale |
2023-03-20 4:16 pm |
Esperion Therapeutics Inc. | ESPR | Koenig Sheldon L. President and CEO |
6,999 | $1.783 | $12,479 | 292,816 (Direct) |
View |
2023-03-17 Sale |
2023-03-20 4:16 pm |
Esperion Therapeutics Inc. | ESPR | Warren Eric Chief Commercial Officer |
526 | $1.7823 | $937 | 70,346 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2024-05-23 Option Award |
2024-05-24 4:18 pm |
N/A 2034-05-23 |
Esperion Therapeutics Inc. | ESPR | CARROLL J MARTIN Director |
55,500 | $0 | 97,150 (Direct) |
View |
2024-05-23 Option Award |
2024-05-24 4:18 pm |
N/A 2034-05-23 |
Esperion Therapeutics Inc. | ESPR | Fischer Seth H. Z. Director |
55,500 | $0 | 60,650 (Direct) |
View |
2024-05-23 Option Award |
2024-05-24 4:17 pm |
N/A 2034-05-23 |
Esperion Therapeutics Inc. | ESPR | Fuhrman Alan Director |
55,500 | $0 | 85,904 (Direct) |
View |
2024-05-23 Option Award |
2024-05-24 4:16 pm |
N/A 2034-05-23 |
Esperion Therapeutics Inc. | ESPR | GOTTO ANTONIO M JR MD D PHIL Director |
55,500 | $0 | 84,099 (Direct) |
View |
2024-05-23 Option Award |
2024-05-24 4:15 pm |
N/A 2034-05-23 |
Esperion Therapeutics Inc. | ESPR | ROCAMBOLI STEPHEN Director |
55,500 | $0 | 68,761 (Direct) |
View |
2024-05-23 Option Award |
2024-05-24 4:14 pm |
N/A 2034-05-23 |
Esperion Therapeutics Inc. | ESPR | Shepard Jay Director |
55,500 | $0 | 84,099 (Direct) |
View |
2024-05-23 Option Award |
2024-05-24 4:13 pm |
N/A 2034-05-23 |
Esperion Therapeutics Inc. | ESPR | VITULLO NICOLE Director |
65,000 | $0 | 65,000 (Direct) |
View |
2024-05-23 Option Award |
2024-05-24 4:13 pm |
N/A 2034-05-23 |
Esperion Therapeutics Inc. | ESPR | Woody Tracy M Director |
65,000 | $0 | 65,000 (Direct) |
View |
2024-03-14 Option Award |
2024-03-15 4:35 pm |
N/A 2034-03-14 |
Esperion Therapeutics Inc. | ESPR | Warren Eric Chief Commercial Officer |
250,000 | $0 | 318,318 (Direct) |
View |
2024-03-14 Option Award |
2024-03-15 4:34 pm |
N/A 2034-03-14 |
Esperion Therapeutics Inc. | ESPR | Foody Joanne M. Chief Medical Officer |
350,000 | $0 | 477,064 (Direct) |
View |
2024-03-14 Option Award |
2024-03-15 4:33 pm |
N/A 2034-03-14 |
Esperion Therapeutics Inc. | ESPR | Looker Benjamin General Counsel |
250,000 | $0 | 333,663 (Direct) |
View |
2024-03-14 Option Award |
2024-03-15 4:32 pm |
N/A 2034-03-14 |
Esperion Therapeutics Inc. | ESPR | Halladay Benjamin Chief Financial Officer |
370,000 | $0 | 443,936 (Direct) |
View |
2024-03-14 Option Award |
2024-03-15 4:30 pm |
N/A 2034-03-14 |
Esperion Therapeutics Inc. | ESPR | Koenig Sheldon L. President and CEO |
1,096,000 | $0 | 1,408,816 (Direct) |
View |
2023-08-08 Option Award |
2023-08-09 4:30 pm |
N/A 2033-08-08 |
Esperion Therapeutics Inc. | ESPR | Foody Joanne M. Chief Medical Officer |
89,300 | $1.62 | 89,300 (Direct) |
View |
2023-06-15 Option Award |
2023-06-16 4:09 pm |
N/A 2033-06-15 |
Esperion Therapeutics Inc. | ESPR | Fuhrman Alan Director |
26,150 | $0 | 51,404 (Direct) |
View |
2023-06-15 Option Award |
2023-06-16 4:09 pm |
N/A 2033-06-15 |
Esperion Therapeutics Inc. | ESPR | Woody Tracy M Director |
26,150 | $0 | 54,566 (Direct) |
View |
2023-06-15 Option Award |
2023-06-16 4:08 pm |
N/A 2033-06-15 |
Esperion Therapeutics Inc. | ESPR | Fischer Seth H. Z. Director |
26,150 | $0 | 26,150 (Direct) |
View |
2023-06-15 Option Award |
2023-06-16 4:08 pm |
N/A 2033-06-15 |
Esperion Therapeutics Inc. | ESPR | CARROLL J MARTIN Director |
26,150 | $0 | 62,650 (Direct) |
View |
2023-06-15 Option Award |
2023-06-16 4:07 pm |
N/A 2033-06-15 |
Esperion Therapeutics Inc. | ESPR | VITULLO NICOLE Director |
26,150 | $0 | 57,918 (Direct) |
View |
2023-06-15 Option Award |
2023-06-16 4:06 pm |
N/A 2033-06-15 |
Esperion Therapeutics Inc. | ESPR | Shepard Jay Director |
26,150 | $0 | 49,599 (Direct) |
View |
2023-06-15 Option Award |
2023-06-16 4:06 pm |
N/A 2033-06-15 |
Esperion Therapeutics Inc. | ESPR | ROCAMBOLI STEPHEN Director |
26,150 | $0 | 34,261 (Direct) |
View |
2023-06-15 Option Award |
2023-06-16 4:05 pm |
N/A 2033-06-15 |
Esperion Therapeutics Inc. | ESPR | GOTTO ANTONIO M JR MD D PHIL Director |
26,150 | $0 | 49,599 (Direct) |
View |
2023-03-14 Option Award |
2023-03-15 09:23 am |
N/A 2033-03-14 |
Esperion Therapeutics Inc. | ESPR | Looker Benjamin General Counsel |
107,400 | $0 | 171,853 (Direct) |
View |
2023-03-14 Option Award |
2023-03-15 09:22 am |
N/A 2033-03-14 |
Esperion Therapeutics Inc. | ESPR | Warren Eric Chief Commercial Officer |
116,800 | $0 | 165,372 (Direct) |
View |